OMCL

Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation

Retrieved on: 
Lundi, mai 6, 2024
Hardware, Health Technology, Environmental, Social and Governance (ESG), Satellite, Technology, Robotics, Pharmaceutical, Professional Services, Philanthropy, Medical Devices, Hospitals, Maritime, Transport, Other Philanthropy, Health, Mercy Ships, Partnership, XT, Patient, OMCL, Multimedia, Nursing

Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced continued support for the global charity Mercy Ships with the donation of solutions from the recently announced XT Amplify program.

Key Points: 
  • Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced continued support for the global charity Mercy Ships with the donation of solutions from the recently announced XT Amplify program.
  • View the full release here: https://www.businesswire.com/news/home/20240506285986/en/
    The largest non-governmental hospital fleet in the world, Mercy Ships travels to developing nations to provide sorely needed, quality healthcare for underserved patients.
  • Omnicell has supported the mission of Mercy Ships through technology donations and technical support since 2017.
  • “Omnicell and Mercy Ships were both founded on the idea of finding a better way,” said Kathleen Nemeth, senior vice president of Investor Relations and liaison to Mercy Ships for Omnicell.

Omnicell to Present at the BofA Securities 2024 Health Care Conference

Retrieved on: 
Vendredi, mai 3, 2024
Technology, Health Technology, Software, Health, Robotics, Pharmaceutical, General Health, Retail, Supply Chain Management, Bank of America, BofA Securities, Conference, OMCL

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m. PT.

Key Points: 
  • Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m. PT.
  • Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/

Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer

Retrieved on: 
Lundi, avril 22, 2024
Weather Underground (weather service), Financial management, CFO, Weather, Executive, Kuipers, Omnicell, General Electric Company, Quantcast, The Weather Company, Business, Forecasting, Information technology, Altera, IPO, Clover Health, Intel, OMCL, Ernst & Young, File, Growth, Yahoo!, Management

FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company, today announced the appointment of Peter Kuipers as Chief Financial Officer (“CFO”), effective as of the day after the filing of the Company’s Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024.

Key Points: 
  • FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company, today announced the appointment of Peter Kuipers as Chief Financial Officer (“CFO”), effective as of the day after the filing of the Company’s Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024.
  • With a wealth of experience and a proven track record in financial management, Mr. Kuipers will drive strategic financial initiatives around profitability, growth and potential new revenue streams.
  • "We are thrilled to welcome Peter to Clover as our new Chief Financial Officer," said Andrew Toy, Chief Executive Officer, Clover Health.
  • “I am honored to join Clover at such an exciting time in its journey,” said Peter Kuipers.

Omnicell Announces First Quarter 2024 Results

Retrieved on: 
Jeudi, mai 2, 2024
Satellite, Pharmaceutical, Hardware, Health, Medical Devices, Robotics, Health Technology, Technology, Pharmacy, Introduction, Environment, XT, Illuminate, OMCL, GAAP, Approximation error

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its first quarter ended March 31, 2024.

Key Points: 
  • Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its first quarter ended March 31, 2024.
  • Total GAAP revenues for the first quarter of 2024 were $246 million, down $44 million, or 15%, from the first quarter of 2023.
  • The Company expects second quarter 2024 product revenues to be between $140 million and $145 million, and second quarter 2024 service revenues to be between $110 million and $115 million.
  • The Company expects second quarter 2024 non-GAAP EBITDA to be between $14 million and $20 million.

Omnicell Announces XT Amplify

Retrieved on: 
Mardi, avril 16, 2024
General Health, Hospitals, Health, Pharmaceutical, Managed Care, Innovation, Refrigeration, Safety, Hospital, SAN, XT, Nursing, Doctor of Pharmacy, OMCL, Multimedia, College, Autonomy, Approximation error, Online shopping

Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell’s XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within pharmacies.

Key Points: 
  • Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell’s XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within pharmacies.
  • We believe Omnicell is nicely positioned to address these current challenges while adapting for the future,” said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell.
  • “We are confident the XT Amplify program will deliver continuous innovation that addresses these evolving and complex needs, while helping customers to maximize outcomes and the value of Omnicell automated dispensing systems currently in use around the globe.”
    The solutions within the multi-year XT Amplify program are intended to enhance nursing efficiency, reduce medication errors and waste, and, ultimately, help health systems achieve the aspirational outcomes outlined in the industry-defined vision of the Autonomous Pharmacy.
  • XT Amplify is intended to enable all healthcare facilities, regardless of where they are in their adoption and utilization of Omnicell’s XT Automated Dispensing System, to solve important challenges today and into the future.

Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024

Retrieved on: 
Lundi, avril 8, 2024
General Health, Health, Pharmaceutical, Technology, Software, OMCL, Conference

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024.

Key Points: 
  • Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024.
  • The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m.
  • All interested parties are invited to listen to the live call and presentation by dialing (888) 550-5424 in the U.S. or (646) 960-0819 in international locations.
  • A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell’s website at https://ir.omnicell.com/events-and-presentations/ .

Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum

Retrieved on: 
Lundi, mars 11, 2024
Health, Technology, Health Technology, Software, General Health, Pharmaceutical, OMCL, Medtech

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024 at 4:30 p.m.

Key Points: 
  • Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024 at 4:30 p.m.
  • ET.
  • Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/

Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024

Retrieved on: 
Mardi, janvier 16, 2024
Health, Hospitals, Other Health, Managed Care, General Health, Pharmaceutical, Conference, OMCL, Pharmacy

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2023, before market open on Thursday, February 8, 2024.

Key Points: 
  • Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2023, before market open on Thursday, February 8, 2024.
  • The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m.
  • All interested parties are invited to listen to the live call and presentation by dialing (888) 550-5424 in the U.S. or (646) 960-0819 in international locations.
  • A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell’s website at https://ir.omnicell.com/events-and-presentations/ .

Omnicell Elects Eileen Voynick to Board of Directors

Retrieved on: 
Jeudi, janvier 11, 2024
Technology, Specialty, Software, Hardware, Pharmaceutical, Health, Robotics, Supply Chain Management, Retail, Consumer Electronics, Thomas Jefferson University, Siebel Systems, Patient, CDK, OMCL, Hospital, Multimedia, CDK Global, SAP, University, Rest, Gartner, Allscripts, SAP Ariba, Oracle, Accenture, Organization, AGS, Photograph, Growth, Management

Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024.

Key Points: 
  • Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024.
  • White, a Class I director who stepped down from the Company’s Board of Directors, effective January 5, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20240111424299/en/
    Omnicell Elects Eileen Voynick to Board of Directors (Photo courtesy of Omnicell, Inc.)
    Ms. Voynick brings over three decades of experience driving sales and operations at global industry leaders, including in the healthcare technology industry, at the executive and board level.
  • “We are pleased to welcome Eileen to the Omnicell Board of Directors,” said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell.

Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference

Retrieved on: 
Lundi, novembre 27, 2023
Health Technology, Pharmaceutical, Health, Conference, Piper Sandler Companies, OMCL, Pharmacy, Hospital, Online shopping, Omnicell

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023 at 1:00 p.m.

Key Points: 
  • Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023 at 1:00 p.m.
  • ET.
  • Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/